- Hem
- Om universitetet
- Hitta person
- Sofia Sandgren
Sofia Sandgren
Anknuten till forskning
Sektionen för klinisk neurovetenskapOm Sofia Sandgren
Ingår i forskargruppen Multipel skleros.
-
The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life
use.
Magnus Johnsson, Kajsa Eriksson, Igal Rosenstein, Lenka Nováková Nyrén, Clas Malmeström, Jan Lycke, Sofia Sandgren, Henrik Zetterberg, Kaj Blennow, Kalle Johansson, Markus Axelsson
Multiple Sclerosis and Related Disorders - 2025 -
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy
controls.
Eline A J Willemse, Sofia Sandgren, Pascal Benkert, Sabine Schaedelin, Aleksandra Maleska Maceski, Johanna Oechtering, Nafiye Genc, Klaus Berger, Marco Hermesdorf, Stefanie Müller, Sebastian Finkener, Juan F Vilchez Gomez, Amar Zadic, Giulio Disanto, Marcus D'Souza, Cristina Granziera, Caroline Pot, Chiara Zecca, Patrice H Lalive, Robert Hoepner, Patrick Roth, Marina Herwerth, Claudio Gobbi, David Leppert, Maximilian Einsiedler, Jens Kuhle
Clinical chemistry and laboratory medicine - 2025 -
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse
activity
Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, Sabine Schaedelin, Johanna Oechtering, Lutz Achtnichts, Patrice H. Lalive, Stefanie Müller, Caroline Pot, Amanda Heslegrave, David Hunt, Jan Lycke, Robert Hoepner, Patrick Roth, Claudio Gobbi, Manuel Comabella, Tobias Derfuss, Ludwig Kappos, Cristina Granziera, Ahmed Abdelhak, David Leppert, Eline A.J. Willemse, Henrik Zetterberg, Jens Kuhle
Multiple Sclerosis Journal - 2025 -
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple
Sclerosis
Sofia Sandgren, Lenka Nováková Nyrén, Markus Axelsson, Igal Rosenstein, Jan Lycke, Clas Malmeström
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION - 2025 -
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment
Response
Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, Johanna Oechtering, Sabine Schaedelin, Lisa Hofer, Amar Zadic, Juan Francisco Vilchez Gomez, Lester Melie-Garcia, Alessandro Cagol, Riccardo Galbusera, Sebastian Finkener, Patrice Lalive, Marjolaine Uginet, Stefanie Müller, Caroline Pot, Amandine Mathias, Renaud Du Pasquier, Robert Hoepner, Andrew Chan, Giulio Disanto, Chiara Zecca, Marcus D’Souza, Lars G. Hemkens, Tobias Derfuss, Özgür Yaldizli, Patrick Roth, Claudio Gobbi, David Brassat, Björn Tackenberg, Henrik Zetterberg, Tjalf Ziemssen, Heinz Wiendl, Klaus Berger, Marco Hermesdorf, Fredrik Piehl, Ludwig Kappos, Cristina Granziera, Ahmed Abdelhak, David Leppert, Eline A.J. Willemse, Pascal Benkert, Jens Kuhle
Annals of Clinical and Translational Neurology - 2025 -
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse
activity
Sarah Lindberg, Sofia Sandgren, Markus Axelsson, Igal Rosenstein, Jan Lycke, Lenka Novakova
MULTIPLE SCLEROSIS JOURNAL - 2025 -
Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple
sclerosis.
Igal Rosenstein, Lenka Nováková Nyrén, Hlin Kvartsberg, Anna Nordin, Sofia Rasch, Elzbieta Rembeza, Sofia Sandgren, Clas Malmeström, Stefanie Fruhwürth, Markus Axelsson, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Journal of Neuroinflammation - 2024 -
The effect of alemtuzumab on neurodegeneration in relapsing-remitting multiple sclerosis: A five-year prospective mono-center
study
Sofia Sandgren, Lenka Novakova, Anna Nordin, Hemin Sabir, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Jan Lycke
MULTIPLE SCLEROSIS AND RELATED DISORDERS - 2024 -
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center
study
Magnus Johnsson, Y. T. Stenberg, H. H. Farman, Kaj Blennow, Henrik Zetterberg, Clas Malmeström, Sofia Sandgren, Igal Rosenstein, Jan Lycke, Markus Axelsson, Lenka Novakova
MULTIPLE SCLEROSIS JOURNAL - 2024 -
lnduction Therapies in Multiple Sclerosis - Clinical and immunological
follow-up
Sofia Sandgren
2024 -
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple
sclerosis.
Sofia Sandgren, Lenka Nováková Nyrén, Anna Nordin, Markus Axelsson, Clas Malmeström, Henrik Zetterberg, Jan Lycke
Frontiers in neurology - 2023 -
The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective
survey
Sofia Sandgren, Lenka Novakova, Markus Axelsson, Firoozeh Amirbeagi, I. Kockum, T. Olsson, Clas Malmeström, Jan Lycke
Frontiers in Neurology - 2023 -
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: An observational
study
Christina Zhukovsky, Sofia Sandgren, Thomas Silfverberg, Sigrun Einarsdottir, Andreas Tolf, Anne Marie Landtblom, Lenka Novakova, Markus Axelsson, Clas Malmeström, Honar Cherif, Kristina Carlson, Jan Lycke, Joachim Burman
Journal of Neurology, Neurosurgery and Psychiatry - 2021 -
Cerebrospinal fluid growth-associated protein 43 in multiple
sclerosis.
Åsa P Sandelius, Sofia Sandgren, Markus Axelsson, Clas Malmeström, Lenka Novakova, Vesna Kostanjevecki, Manu Vandijck, Kaj Blennow, Henrik Zetterberg, Jan Lycke
Scientific reports - 2019